$2.54 Billion is the total value of DEERFIELD MANAGEMENT COMPANY, L.P. (SERIES C)'s 98 reported holdings in Q4 2017. The portfolio turnover from Q3 2017 to Q4 2017 was 40.7% .
| Value | Shares | ↓ Weighting | ||||||
|---|---|---|---|---|---|---|---|---|
| MNKKQ | Buy | MALLINCKRODT PUB LTD CO | $130,081,000 | +87.1% | 5,766,000 | +210.0% | 5.12% | +63.5% |
| MYL | Sell | MYLAN N V | $105,928,000 | +7.1% | 2,503,611 | -20.6% | 4.17% | -6.4% |
| HZNP | Sell | HORIZON PHARMA PLC | $92,592,000 | +5.6% | 6,341,894 | -8.3% | 3.64% | -7.8% |
| DXCM | Buy | DEXCOM INC | $88,048,000 | +26.7% | 1,534,211 | +8.0% | 3.46% | +10.7% |
| GKOS | Buy | GLAUKOS CORP | $85,749,000 | +2.8% | 3,343,045 | +32.3% | 3.38% | -10.1% |
| AVXS | Sell | AVEXIS INC | $83,644,000 | -44.1% | 755,798 | -51.2% | 3.29% | -51.2% |
| ANAB | Sell | ANAPTYSBIO INC | $81,833,000 | +184.0% | 812,484 | -1.4% | 3.22% | +148.2% |
| HORIZON PHARMA INVT LTDnote 2.500% 3/1 | $68,886,000 | +3.0% | 74,100,000 | 0.0% | 2.71% | -10.0% | ||
| LCI | Buy | LANNET INC | $63,041,000 | +135.1% | 2,717,287 | +87.0% | 2.48% | +105.4% |
| MCK | Sell | MCKESSON CORP | $61,569,000 | -45.0% | 394,801 | -45.8% | 2.42% | -52.0% |
| ACRS | Buy | ACLARIS THERAPEUTICS INC | $55,076,000 | +35.2% | 2,233,416 | +41.5% | 2.17% | +18.1% |
| EDIT | EDITAS MEDICINE INC | $52,530,000 | +28.0% | 1,709,400 | 0.0% | 2.07% | +11.8% | |
| DBVT | Buy | DBV TECHNOLOGIES S Asponsored adr | $51,787,000 | +86.0% | 2,105,180 | +221.0% | 2.04% | +62.5% |
| ARNA | Buy | ARENA PHARMACEUTICALS INC | $51,722,000 | +89.2% | 1,522,566 | +42.0% | 2.04% | +65.3% |
| PODD | Buy | INSULET CORP | $48,685,000 | +77.8% | 705,573 | +42.0% | 1.92% | +55.4% |
| ISIS PHARMACEUTICALS INC DELnote 1.000%11/1 | $48,392,000 | -0.2% | 45,700,000 | 0.0% | 1.90% | -12.8% | ||
| XENT | Buy | INTERSECT ENT INC | $47,574,000 | +26.2% | 1,468,341 | +21.4% | 1.87% | +10.2% |
| KEMPHARM INCnote 5.500% 2/0 | $45,750,000 | +0.1% | 75,000,000 | 0.0% | 1.80% | -12.5% | ||
| GWPH | Sell | GW PHARMACEUTICALS PLCads | $44,775,000 | +21.6% | 339,180 | -6.5% | 1.76% | +6.3% |
| MOH | Buy | MOLINA HEALTHCARE INC | $43,554,000 | +145.5% | 568,000 | +120.2% | 1.71% | +114.5% |
| MYOK | Sell | MYOKARDIA INC | $42,129,000 | -28.0% | 1,000,680 | -26.7% | 1.66% | -37.1% |
| TRINITY BIOTECH INVT LTDnote 4.000% 4/0 | $39,492,000 | +3.4% | 48,000,000 | 0.0% | 1.55% | -9.7% | ||
| BOLD | Sell | AUDENTES THERAPEUTICS INC | $37,204,000 | -12.9% | 1,190,516 | -22.0% | 1.46% | -23.9% |
| ENDOLOGIX INCnote 3.250%11/0 | $36,112,000 | +3.1% | 40,500,000 | 0.0% | 1.42% | -9.9% | ||
| RVNC | New | REVANCE THERAPEUTICS INC | $35,750,000 | – | 1,000,000 | +100.0% | 1.41% | – |
| BCRX | Buy | BIOCRYST PHARMACEUTICALS | $35,418,000 | +35.9% | 7,213,393 | +45.0% | 1.39% | +18.7% |
| SEM | Buy | SELECT MED HLDGS CORP | $32,794,000 | +43.0% | 1,858,000 | +55.5% | 1.29% | +25.0% |
| AVDL | Buy | AVADEL PHARMACEUTICALS PLCsponsored adr | $32,435,000 | -15.5% | 3,955,494 | +8.2% | 1.28% | -26.1% |
| ASND | Sell | ASCENDIS PHARMA A Ssponsored adr | $31,607,000 | +2.6% | 789,000 | -7.2% | 1.24% | -10.4% |
| DVA | New | DAVITA INC | $30,706,000 | – | 425,000 | +100.0% | 1.21% | – |
| BPMC | Buy | BLUEPRINT MEDICINES CORP | $29,862,000 | +111.1% | 396,000 | +95.1% | 1.18% | +84.5% |
| ANTM | New | ANTHEM INC | $29,251,000 | – | 130,000 | +100.0% | 1.15% | – |
| AERI | Sell | AERIE PHARMACEUTICALS INC | $28,922,000 | -5.9% | 484,055 | -23.5% | 1.14% | -17.8% |
| Sell | INTERCEPT PHARMACEUTICALS INnote 3.250% 7/0 | $28,879,000 | -27.2% | 36,000,000 | -29.4% | 1.14% | -36.4% | |
| NEVRO CORPnote 1.750% 6/0 | $28,890,000 | -11.8% | 27,600,000 | 0.0% | 1.14% | -23.0% | ||
| NTRA | Buy | NATERA INC | $26,258,000 | -6.6% | 2,920,856 | +33.9% | 1.03% | -18.5% |
| XLRN | ACCELERON PHARMA INC | $26,101,000 | +13.7% | 615,000 | 0.0% | 1.03% | -0.7% | |
| ACHC | New | ACADIA HEALTHCARE COMPANY IN | $24,179,000 | – | 741,016 | +100.0% | 0.95% | – |
| EVHC | New | ENVISION HEALTHCARE CORP | $23,363,000 | – | 676,000 | +100.0% | 0.92% | – |
| ARGX | Sell | ARGENX SEsponsored adr | $23,107,000 | +100.8% | 365,961 | -28.1% | 0.91% | +75.5% |
| K2M GROUP HLDGS INCnote 4.125% 8/1 | $22,847,000 | -6.7% | 20,000,000 | 0.0% | 0.90% | -18.6% | ||
| New | DEPOMED INCnote 2.500% 9/0 | $22,776,000 | – | 27,019,000 | +100.0% | 0.90% | – | |
| Buy | AMAG PHARMACEUTICALS INCnote 3.250% 6/0 | $21,759,000 | +38.2% | 25,250,000 | +55.4% | 0.86% | +20.7% | |
| IMMU | Buy | IMMUNOMEDICS INC | $21,015,000 | +158.3% | 1,300,448 | +123.4% | 0.83% | +126.0% |
| OXFD | Buy | OXFORD IMMUNOTEC GLOBAL PLC | $17,658,000 | +11.1% | 1,264,000 | +33.7% | 0.70% | -2.9% |
| EHTH | Buy | EHEALTH INC | $17,612,000 | +9.5% | 1,013,916 | +50.7% | 0.69% | -4.3% |
| REPH | RECRO PHARMA INC | $17,591,000 | +3.0% | 1,901,685 | 0.0% | 0.69% | -10.0% | |
| RYTM | New | RHYTHM PHARMACEUTICALS INC | $16,913,000 | – | 582,010 | +100.0% | 0.67% | – |
| AACH | Buy | AAC HLDGS INC | $16,859,000 | -2.0% | 1,873,276 | +8.1% | 0.66% | -14.3% |
| ARDX | Sell | ARDELYX INC | $16,299,000 | +6.0% | 2,469,580 | -10.1% | 0.64% | -7.5% |
| CTMX | Sell | CYTOMX THERAPEUTICS INC | $15,903,000 | +15.6% | 753,322 | -0.5% | 0.63% | +1.1% |
| NVTA | Buy | INVITAE CORP | $15,645,000 | +85.5% | 1,723,000 | +91.4% | 0.62% | +62.1% |
| AGIO | Buy | AGIOS PHARMACEUTICALS INC | $15,035,000 | +8.3% | 262,984 | +26.4% | 0.59% | -5.3% |
| UHS | New | UNIVERSAL HLTH SVCS INCcl b | $14,962,000 | – | 132,000 | +100.0% | 0.59% | – |
| PTLA | PORTOLA PHARMACEUTICALS INC | $14,533,000 | -9.9% | 298,545 | 0.0% | 0.57% | -21.3% | |
| BLUE | New | BLUEBIRD BIO INC | $14,248,000 | – | 80,000 | +100.0% | 0.56% | – |
| LOXO | LOXO ONCOLOGY INC | $14,226,000 | -8.6% | 169,000 | 0.0% | 0.56% | -20.1% | |
| AEGERION PHARMACEUTICALS INCnote 2.000% 8/1 | $13,195,000 | -1.2% | 16,600,000 | 0.0% | 0.52% | -13.8% | ||
| EPZM | Buy | EPIZYME INC | $12,670,000 | -5.1% | 1,009,526 | +44.1% | 0.50% | -17.0% |
| SYRS | SYROS PHARMACEUTICALS INC | $12,347,000 | -33.9% | 1,268,945 | 0.0% | 0.49% | -42.2% | |
| GLPG | GALAPAGOS NVspon adr | $12,189,000 | -7.9% | 130,000 | 0.0% | 0.48% | -19.5% | |
| XNCR | XENCOR INC | $11,442,000 | -4.4% | 522,000 | 0.0% | 0.45% | -16.5% | |
| APLS | New | APELLIS PHARMACEUTICALS INC | $11,132,000 | – | 513,000 | +100.0% | 0.44% | – |
| RETA | Buy | REATA PHARMACEUTICALS INCcl a | $11,045,000 | +86.9% | 390,000 | +105.3% | 0.44% | +63.5% |
| WVE | Sell | WAVE LIFE SCIENCES LTD | $11,045,000 | -12.4% | 314,674 | -45.7% | 0.44% | -23.4% |
| WBA | New | WALGREENS BOOTS ALLIANCE INC | $10,530,000 | – | 145,000 | +100.0% | 0.41% | – |
| ALLSCRIPTS HEALTHCARE SOLUTNnote 1.250% 7/0 | $10,351,000 | +0.5% | 9,671,000 | 0.0% | 0.41% | -12.3% | ||
| ALPN | Sell | ALPINE IMMUNE SCIENCES INC | $10,227,000 | -5.5% | 913,100 | -2.1% | 0.40% | -17.6% |
| FPRX | New | FIVE PRIME THERAPEUTICS INC | $9,880,000 | – | 450,728 | +100.0% | 0.39% | – |
| BHVN | Buy | BIOHAVEN PHARMACTL HLDG CO L | $9,200,000 | +49.2% | 341,000 | +106.7% | 0.36% | +30.2% |
| BIOS | Buy | BIOSCRIP INC | $9,091,000 | +198.6% | 3,124,000 | +182.2% | 0.36% | +161.3% |
| RGNX | New | REGENXBIO INC | $8,522,000 | – | 256,300 | +100.0% | 0.34% | – |
| SYBX | SYNLOGIC INC | $8,246,000 | -49.0% | 850,143 | 0.0% | 0.32% | -55.4% | |
| ALIM | ALIMERA SCIENCES INC | $8,050,000 | -1.5% | 6,052,935 | 0.0% | 0.32% | -13.9% | |
| DCPH | Buy | DECIPHERA PHARMACEUTICALS IN | $7,617,000 | +23.4% | 336,009 | +3.4% | 0.30% | +7.9% |
| NEOS | Sell | NEOS THERAPEUTICS INC | $7,607,000 | -47.0% | 745,767 | -52.5% | 0.30% | -53.8% |
| IVTY | INVUITY INC | $7,299,000 | -30.3% | 1,177,229 | 0.0% | 0.29% | -39.2% | |
| MRTX | New | MIRATI THERAPEUTICS INC | $6,844,000 | – | 375,000 | +100.0% | 0.27% | – |
| MCK | MCKESSON CORPcall | $6,737,000 | +1.5% | 43,200 | 0.0% | 0.26% | -11.4% | |
| SRRA | Sell | SIERRA ONCOLOGY INC | $6,569,000 | +51.4% | 1,761,092 | -37.1% | 0.26% | +32.8% |
| ALNA | New | ALLENA PHARMACEUTICALS INC | $6,087,000 | – | 605,100 | +100.0% | 0.24% | – |
| STDY | STEADYMED LTD | $5,250,000 | +10.5% | 1,418,787 | 0.0% | 0.21% | -3.3% | |
| PTGX | New | PROTAGONIST THERAPEUTICS INC | $4,680,000 | – | 225,000 | +100.0% | 0.18% | – |
| EIGR | New | EIGER BIOPHARMACEUTICALS INC | $4,185,000 | – | 300,000 | +100.0% | 0.16% | – |
| IFRX | New | INFLARX NV | $3,666,000 | – | 175,000 | +100.0% | 0.14% | – |
| TSRO | New | TESARO INC | $3,555,000 | – | 42,893 | +100.0% | 0.14% | – |
| FOMX | Sell | FOAMIX PHARMACEUTICALS LTD | $3,011,000 | -33.6% | 501,000 | -38.7% | 0.12% | -41.7% |
| OBLN | Buy | OBALON THERAPEUTICS INC | $2,950,000 | -11.9% | 446,284 | +27.0% | 0.12% | -23.2% |
| PRTO | PROTEON THERAPEUTICS INC | $2,327,000 | -5.0% | 1,224,899 | 0.0% | 0.09% | -16.4% | |
| ARLZ | ARALEZ PHARMACEUTICALS INC | $2,335,000 | -38.0% | 1,644,583 | 0.0% | 0.09% | -45.9% | |
| PFNX | New | PFENEX INC | $2,208,000 | – | 830,216 | +100.0% | 0.09% | – |
| VYGR | VOYAGER THERAPEUTICS INC | $1,953,000 | -19.4% | 117,647 | 0.0% | 0.08% | -29.4% | |
| MDXG | MIMEDX GROUP INC | $1,892,000 | +6.2% | 150,000 | 0.0% | 0.07% | -7.5% | |
| ASNS | New | ARSANIS INC | $1,679,000 | – | 131,548 | +100.0% | 0.07% | – |
| KIDS | New | ORTHOPEDIATRICS CORP | $1,118,000 | – | 58,247 | +100.0% | 0.04% | – |
| AKTX | Sell | AKARI THERAPEUTICS PLCsponsored adr | $1,082,000 | -59.4% | 249,785 | -42.4% | 0.04% | -64.2% |
| NCNA | Sell | NUCANA PLCsponsored adr | $835,000 | -89.3% | 82,637 | -80.6% | 0.03% | -90.6% |
| RARX | Sell | RA PHARMACEUTICALS INC | $673,000 | -54.9% | 79,150 | -22.5% | 0.03% | -61.2% |
| ITCI | Exit | INTRA CELLULAR THERAPIES INC | $0 | – | -118,116 | -100.0% | -0.08% | – |
| SAGE | Exit | SAGE THERAPEUTICS INC | $0 | – | -68,000 | -100.0% | -0.19% | – |
| AGRX | Exit | AGILE THERAPEUTICS INC | $0 | – | -1,221,775 | -100.0% | -0.24% | – |
| MYOV | Exit | MYOVANT SCIENCES LTD | $0 | – | -400,685 | -100.0% | -0.28% | – |
| AXGN | Exit | AXOGEN INC | $0 | – | -344,428 | -100.0% | -0.30% | – |
| AXGT | Exit | AXOVANT SCIENCES LTD | $0 | – | -1,052,000 | -100.0% | -0.33% | – |
| CMTA | Exit | CLEMENTIA PHARMACEUTICALS IN | $0 | – | -462,387 | -100.0% | -0.35% | – |
| MRNS | Exit | MARINUS PHARMACEUTICALS INC | $0 | – | -1,355,000 | -100.0% | -0.36% | – |
| SGMO | Exit | SANGAMO THERAPEUTICS INC | $0 | – | -653,000 | -100.0% | -0.44% | – |
| CNC | Exit | CENTENE CORP DEL | $0 | – | -102,000 | -100.0% | -0.44% | – |
| AAAP | Exit | ADVANCED ACCELERATOR APPLICsponsored ads | $0 | – | -218,000 | -100.0% | -0.66% | – |
| SELB | Exit | SELECTA BIOSCIENCES INC | $0 | – | -951,629 | -100.0% | -0.78% | – |
| Exit | FLUIDIGM CORP DELnote 2.750% 2/0 | $0 | – | -27,715,000 | -100.0% | -0.91% | – | |
| PDCO | Exit | PATTERSON COMPANIES INC | $0 | – | -566,000 | -100.0% | -0.98% | – |
| NXTM | Exit | NXSTAGE MEDICAL INC | $0 | – | -1,579,285 | -100.0% | -1.96% | – |
Other managers
Other managers that, in addition to the filing manager(s), that filed the EDGAR filing(s):
Original filings
The following EDGAR filing(s) were analyzed to create this report:
- View 13F-HR filed 2018-02-14
Top long-term holdings
| Name | Quarters owned | Latest quarter owned | Max weighting |
|---|---|---|---|
| AERIE PHARMACEUTICALS INC | 36 | Q3 2022 | 3.6% |
| CENTENE CORP DEL | 30 | Q3 2023 | 3.0% |
| BIOCRYST PHARMACEUTICALS INC | 29 | Q3 2023 | 2.2% |
| MOLINA HEALTHCARE INC | 26 | Q3 2022 | 1.7% |
| EHEALTH INC | 25 | Q3 2020 | 2.0% |
| INTERCEPT PHARMACEUTICALS IN | 24 | Q1 2023 | 2.2% |
| MYLAN NV | 23 | Q3 2020 | 6.2% |
| PORTOLA PHARMACEUTICALS INC | 23 | Q1 2019 | 6.0% |
| BROOKDALE SR LIVING INC | 23 | Q3 2023 | 2.2% |
| ALIMERA SCIENCES INC | 23 | Q3 2019 | 0.8% |
View DEERFIELD MANAGEMENT COMPANY, L.P. (SERIES C)'s complete holdings history.
Latest significant ownerships (13-D/G)
| Filed | Shares | Percentage | |
|---|---|---|---|
| DA32 Life Science Tech Acquisition Corp. | August 01, 2023 | 5,145,000 | 91.1% |
| CareMax, Inc. | March 13, 2023 | 18,691,423 | 16.4% |
| CareMax, Inc. | June 02, 2022 | 18,691,423 | 20.7% |
View DEERFIELD MANAGEMENT COMPANY, L.P. (SERIES C)'s complete significant-ownership history.
Latest filings
| Type | Filed |
|---|---|
| 3 | 2024-03-19 |
| 4 | 2024-03-19 |
| 4 | 2024-03-12 |
| 3 | 2024-03-08 |
| 4 | 2024-02-16 |
| 13F-HR | 2024-02-14 |
| 4 | 2024-02-08 |
| 3 | 2024-02-01 |
| 4 | 2023-11-21 |
| 13F-HR | 2023-11-14 |
View DEERFIELD MANAGEMENT COMPANY, L.P. (SERIES C)'s complete filings history.
All filings
- Holdings (13F-HR)
- Significant ownership (13-D/G)
- Insider transactions (4, 5, 6)
- Events (8-K)
- Shareholder votes (proxy)
View complete filings history.